Key result
Standard macrophage markers lose specificity after myocardial injury as fibroblasts adopt macrophage traits.
Why the study?
Reliable tools for macrophage identification in mouse tissues are critical due to organ-specific expression patterns and non-specific labeling that limit current markers' usefulness.
Highlights the critical need for careful, context-specific selection of macrophage markers in preclinical research, given their substantial heterogeneity and potential cross-reactivity with fibroblasts after injury.
Requires context-specific macrophage marker validation in preclinical MI models; challenges specificity assumptions and leaves clinical translation open.
Reliable tools for macrophage identification in mouse tissues are critical for studies investigating inflammatory and reparative responses. Transgenic reporter mice and anti-macrophage antibodies have been used as "specific pan-macrophage" markers in many studies; however, organ-specific patterns of expression and non-specific labeling of other cell types, such as fibroblasts, may limit their usefulness. Our study provides a systematic comparison of macrophage labeling patterns in normal and injured mouse tissues, using the CX3CR1 and CSF1R macrophage reporter lines and anti-macrophage antibodies. Moreover, we tested the specificity of macrophage antibodies using the fibroblast-specific PDGFR[Formula: see text] reporter line. Mouse macrophages exhibit organ-specific differences in expression of macrophage markers. Hepatic macrophages are labeled for CSF1R, Mac2 and F4/80, but lack CX3CR1 expression, whereas in the lung, the CSF1R+/Mac2+/Mac3+ macrophage population is not labeled with F4/80. In the splenic red pulp, subpopulations of CSF1R+/F4/80+/Mac3+cells were labeled with Mac2, CX3CR1 and lysozyme M. In the kidney, Mac2, Mac3 and lysozyme M labeled a fraction of the CSF1R+ and CX3CR1+ macrophages, but also stained tubular epithelial cells. In normal hearts, the majority of CSF1R+ and CX3CR1+ cells were not detected with anti-macrophage antibodies. Myocardial infarction was associated with marked expansion of the CSF1R+ and CX3CR1+ populations that peaked during the proliferative phase of cardiac repair, and also expressed Mac2, Mac3 and lysozyme M. In normal mouse tissues, a small fraction of cells labeled with anti-macrophage antibodies were identified as PDGFR[Formula: see text]+ fibroblasts, using a reporter system. The population of PDGFR[Formula: see text]+ cells expressing macrophage markers expanded following injury, likely reflecting emergence of cellular phenotypes with both fibroblast and macrophage characteristics. In conclusion, mouse macrophages exhibit remarkable heterogeneity. Selection of the most appropriate markers for identification of macrophages in mouse tissues is dependent on the organ and the pathologic condition studied.
No takes yet. Share an insight, caveat, or question.
A 2022 study studied Normal tissues and myocardial infarction (preclinical model). Macrophage reporter lines and antibodies was evaluated on Specificity and labeling patterns of macrophages. Mouse macrophages exhibit remarkable organ-specific heterogeneity, and standard macrophage markers show reduced specificity following myocardial injury as fibroblasts acquire macrophage characteristics.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: